final program

 

Saturday,
July 28, 2012
Sunday,
July 29, 2012
Monday,
July 30, 2012
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

Monday, July 30, 2012

08:30-11:00   HALL A
 

PL15    Plenary Session:
HEART FAILURE: NOVEL RISK FACTORS, BIOMARKERS, PREVENTION AND NEW TREATMENT OPTIONS
 

Chairs:
U. Elkayam, Los Angeles, CA, USA
H.N. Sabbah
, Detroit, MI, USA

 
08:30 STEPS TO PREVENT HEART FAILURE (Invited Lecture)
H.K. Reddy, University of Arkansas for Medical Sciences, Little Rock, AR, USA
385
08:45 THYROID HORMONE DYSFUNCTION AND HEART FAILURE: FEAR OF OVERTREATMENT MAY BE CAUSING HARM (Invited Lecture)
A.M. Gerdes, New York College of Osteopathic Medicine, Old Westbury, NY, USA
 
386
09:00 INTERNATIONAL CLINICAL TRIALS: GOOD FOR THE NEW WORLD BAD FOR THE THIRD WORLD (Invited Lecture)
S. Goldstein
, Henry Ford Hospital, Detroit, MI, USA
387
09:15 AGING AND HEART FAILURE: ROLE OF HEALING AFTER MYOCARDIAL INFARCTION (Invited Lecture)
B.I. Jugdutt, University of Alberta and Hospitals, Edmonton, Alberta, Canada
388
09:30 BAROREFLEX STIMULATION FOR THE TREATMENT OF HEART FAILURE (Invited Lecture)
H.N. Sabbah
, Henry Ford Hospital, Detroit, MI, USA
389
09:45 NOVEL HEMODYNAMIC RISK FACTORS FOR NEW - ONSET HEART FAILURE IN THE GENERAL POPULATION (Invited Lecture)
J.A. Chirinos, University of Pennsylvania School of Medicine Philadelphia, PA, USA
390
10:00 MANAGEMENT OF PATIENT WITH ADVANCED HEART FAILURE (Invited Lecture)
M.H. Pitzalis
, East Carolina University, The Brody School of Medicine, Greenville, NC, USA
391
10:15 BLOOD UREA NITROGEN: AN EMERGING BIOMARKER FOR NEUROHORMONAL ACTIVATION IN HEART FAILURE (Invited Lecture)
A. Kazory, University of Florida, Gainesville, FL, USA
392
10:30 DIET IN THE PREVENTION AND MANAGEMENT OF HEART FAILURE (Invited Lecture)
C. Chrysohoou, First Cardiology Clinic, University of Athens, Greece
393
10:45 INCREASED RENAL ENAC SUBUNITS AND SODIUM RETENTION IN RATS WITH CHRONIC HEART FAILURE (Invited Lecture)
H. Zheng, University of Nebraska Medical Center, Omaha, NE, USA
394
11:00 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 30,2012
08:30-10:45   HALL B

 

PL16   Plenary Session:
NOVEL CARDIOPROTECTIVE THERAPIES

Chairs:
Y. Birnbaum, Houston, TX, USA
P.K. Singal
, Winnipeg, MB, Canada

 

08:30 EARLY INSULIN TREATMENT AMELIORATES POST-ISCHEMIC HEART FAILURE BY INHIBITION OF MYOCARDIAL CAMKII AND P38 MAPK ACTIVITY (Invited Lecture)
F. Gao, The Fourth Military Medical University, Xi'an, China
395
08:45 THE ROLE OF MYD88 IN THE ANTI-APOPTOTIC EFFECTS OF INTERLEUKIN-10 (Invited Lecture)
P.K. Singal
, St. Boniface Hospital Research Centre, Winnipeg, MB, Canada
 
396
09:00 AMPLIFICATION OF THE MYOCARDIAL INFARCT SIZE LIMITING EFFECTS OF GLP-1 RECEPTOR ACTIVATION BY CILOSTAZOL, A PHOSPHODIESTERASE III INHIBITOR (Invited Lecture)
Y. Ye, Y. Birnbaum, Baylor College of Medicine, Houston, TX, USA
 
397
09:15 MOLECULAR MECHANISMS OF THE BENEFICIAL CARDIOVASCULAR EFFECTS OF TRANS-RESVERATROL (Invited Lecture)
U. Forstermann
, Johannes Gutenberg University Medical Center, Mainz, Germany
398
09:30 OXYTOCIN – AN ANTIOBESITY AND CARDIOPROTECTIVE MOLECULE (Invited Lecture)
D. Jezova, Institute of Experimental Endocrinology, Bratislava, Slovakia
399
09:45 LEFT VENTRICULAR FAILURE PRODUCES PROFOUND LUNG REMODELING AND PULMONARY HYPERTENSION: HEART FAILURE CAUSES SEVERE LUNG DISEASE (Invited Lecture)
Y. Chen, University of Minnesota, Minneapolis, MN, USA
400
10:00

THERAPEUTIC POTENTIAL OF TISSUE INHIBITOR OF METALLOPROTEINASES (TIMPS) FOLLOWING MYOCARDIAL INFARCTION (Invited Lecture)
Z. Kassiri, University of Alberta, Edmonton, AB, Canada

401
10:15 TRICYCLIC PSYCHIATRIC ANTIDEPRESSANTS AS ALPHA2A ADRENERGIC RECEPTOR LIGANDS MODULATING RECEPTOR FUNCTION (Invited Lecture)
Q. Wang
, University of Alabama at Birmingham, AL, USA
402
10:30 THE INFLUENCE OF ACUTE MATRIX METALLOPROTEINASE ACTIVITY ON MYOCARDIAL DYSFUNCTION ASSOCIATED WITH URGENT CARDIAC SURGERY: CARDIOPROTECTIVE EFFECTS OF INHIBITION
E.S. Teh, D.J. Chambers The Rayne Institute (King's College London), London, UK
403
10:45 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 30,2012
08:30 - 10:15   HALL C
  S33   Session:  
INTERVENTIONAL CARDIOLOGY

Chairs:
B.F. Uretsky, Little Rock, AR, USA
G.W. Vetrovec, Richmond, VA, USA
 
08:30 DEDICATED STENT TREATMENT VERSUS STANDARD TREATMENT FOR CORORNARY BIFURCATIONS: LONG-TERM FOLLOW-UP
T. Gil-Jimenez, L.A. Inigo-Garcia, J.R. Siles-Rubio, A. Ramirez-Moreno, L. Fernandez-Lopez, C. Medina-Palomo, M. Pombo-Jimenez, J.F. Munoz-Bellido, O. Sanz-Vazquez, F. Ruiz-Mateas, Hospital Costa de Sol, Marbella, Spain
404
08:45 A MULTIDISCIPLINARY EFFORT TO DECREASE VASCULAR COMPLICATIONS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (PCI)
P. Muthusamy, D. Busman, D. Wohns, Grand Rapids Medical Education Partners, Grand Rapids, MI, USA
405
09:00 META-ANALYSIS OF TRIALS INVOLVING CHRONIC TOTAL OCCLUSIONS
M. Khan, M-R. Movahed, The Southern Arizona VA Health Care System, University of Arizona Sarver Heart Center, Tucson, AZ, USA
406
09:15 TRANSRADIAL CATHETERIZATION AND M-SIGN
G.H. Abusaid, W.I. Khalife, University of Texas Medical Branch, Galveston, TX, USA
407
09:30 ADJUNCTIVE USE OF CORONARY EXCIMER LASER FOR LESIONS UNSUCCESSFULLY CROSSED WITH CORONARY BALLOONS
A. Singh, G. Srinivas, S. Singhal, D. Jauhar, B. Kaplan, R. Jauhar, B. Arkonac, Long Island Jewish Medical Center, New Hyde Park, NY, USA
408
09:45 GENDER AND AGE PREDICT HYPORESPONSIVENESS TO CLOPIDOGREL BY PLATELET FUNCTION TESTING IN EMERENCY DEPARTMENT
H.K. Reddy, R. Sharma, S.W. Erickson, D.J. Voelker, M. Moazazi, H. Dod, V.N. Singh, J.D. Marsh, R.K. Sharma, University of Arkansas for Medical Sciences, Little Rock, AR, USA
409
10:00 CLINICALLY RELEVANT COMPOSITE OUTCOMES IN THE TREATMENT OF SYMPTOMATIC CORONARY ARTERY DISEASE (CAD)
E.L. Woollard, L.J. Wood, K.V. Woollard, T.G. Briffa, University of Western Australia, Perth WA, Australia
410
10:15 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 30,2012
11:15-14:00   HALL A
 

PL17    Plenary Session:
OBESITY, METABOLIC SYNDROME AND DIABETES
Joint Session with the American Society for Preventive Cardiology 

Chairs:
M.A. Alpert, Columbia, MO, USA
N.D. Wong, Irvine, CA, USA

 
11:15 THE OBESITY PARADOX AND CARDIOVASCULAR DISEASE (Invited Lecture)
M.A. Alpert, University of Missouri-Columbia School of Medicine, Columbia, MO, USA
411
11:30 ENDOTHELIAL DYSFUNCTION IN HYPERTENSION, DIABETES AND OBESITY (Invited Lecture)
T. Malinski, Chemisty and Biochemistry Ohio University, Athens, OH, USA
413
11:45 SCREENING FOR CVD IN METABOLIC SYNDROME AND DIABETES? (Invited Lecture)
N.D. Wong
, Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, CA, USA
414
12:00 CARDIOVASCULAR DISEASE PREVENTION IN PATIENTS WITH DIABETES (Invited Lecture)
G.L. Fung
, UCSF Medical Center at Mt. Zion, San Francisco, CA, USA
415
12:15 REFINING RISK ASSESSMENT IN DIABETIC DYSLIPIDEMIA AFTER ACHIEVING LDL-C GOAL (Invited Lecture)
O.P. Ganda, Harvard Medical School, Boston, MA, USA
485
12:30 NON-INVASIVE ULTRASOUND EVALUATION OF SUBCLINICAL ATHEROSCLEROSIS: PROGRESS AND PITFALLS (Invited Lecture)
J.M. Gardin, Hackensack University Medical Center, Hackensack, NJ, USA
416
12:45 GENETIC RISK FACTORS FOR CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES (Invited Lecture)
L. Qi, Harvard School of Public Health, Boston, MA, USA
417
13:00 EFFICACY AND SAFETY OF SAXAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES AND HISTORY OF CARDIOVASCULAR DISEASE
W. Cook
, B. Bryzinski, J. Slater, M. Donovan, E. Allen, Medical Affairs, AstraZeneca, Wilmington, DE, USA
418
13:15 ELEVATED AMBULATORY PULSE PRESSURE IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES: THE HYGIA PROJECT
D.E. Ayala, A. Moya, S. Gomara, J.J. Crespo, M.C. Castineira, J.J. Sanchez, M. Dominguez, A. Mojon, J.R. Fernandez, R.C. Hermida, University of Vigo, Spain
 
419
13:30 AMBULATORY BLOOD PRESSURE THRESHOLDS FOR DIAGNOSIS OF HYPERTENSION IN TYPE 2 DIABETES BASED ON CARDIOVASCULAR OUTCOMES
R.C. Hermida, D.E. Ayala, A. Mojon, J.R. Fernandez, University of Vigo, Spain
420
13:45 EFFICACY AND SAFETY OF SAXAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES STRATIFIED BY CARDIOVASCULAR RISK FACTORS
W. Cook
, J. Slater, B. Bryzinski, M. Donovan, E. Allen Medical Affairs, AstraZeneca, Wilmington, DE, USA
421
14:00 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 30,2012
11:15-13:45   HALL B

 

S34   Session:
HEART FAILURE: PATHOGENESIS, MANAGEMENT, OUTCOMES

Chairs:
B.I. Jugdutt, Edmonton, AB, Canada
M.H. Pitzalis, Greenville, NC, USA

 

11:15 BIOIMPEDANCE VECTOR ANALYSIS IN THE DIAGNOSIS OF ACUTE DECOMPENSATED HEART FAILURE IN THE EMERGENCY DEPARTMENT
D.W. Kehl, R. Choudhary, B. Dieffenbach, P. Clopton, P.R. Taub, A.S. Maisel, University of California at San Diego, San Diego, CA, USA
422
11:30 THE ROLE OF RIGHT VENTRICULAR FUNCTION IN PEDIATRIC IDIOPATHIC DILATED CARDIOMYOPATHY
A. Groner
, J. Yu, H. Ko, J. Nielsen, I. Lytrivi, I. Parness, S. Srivastava Mount Sinai Medical Center, New York, NY, USA
423
11:45 IS "CHRONOTROPIC INCOMPETENCE" AN ADAPTIVE MECHANISM IN SYSTOLIC HEART FAILURE?
J. Shirani, T.H. LeJemtel, St. Luke's University Health Network, Bethlehem, PA, USA
424
12:00 PROGNOSTIC UTILITY OF QRS FRAGMENTATION IN PATIENTS WITH NON ISCHEMIC CARDIOMYOPATHY
V.M. Alla, O. Bansal, S. Kanuri, M.B. Jayanna, Y.M. Reddy,
M. Kaushik, D. Lakkireddy, A. Mooss, Creighton University, Omaha, NE, USA
425
12:15 TAKOTSUBO CARDIOMYOPATHY AND STROKE
M.L. Young, J. Stoehr, M.I. Aguilar, F.D. Fortuin, Midwestern University, Glendale, AZ, USA
426
12:30 MICRORNAS AS A WINDOW INTO CELLULAR PROCESSES OCCURRING SOON AFTER ACUTE MYOCARDIAL INFARCTION
C. Watt, P. Sirish, N. Chiamvimonvat, J. López University of California, Davis, Sacramento, CA, USA
427
12:45 EVALUATION OF ATRIAL ASYNCHRONY IN HEART FAILURE PATIENTS BY 2D SPECKLE TRACKING USING VELOCITY VECTOR IMAGING
M. Esmaeilzadeh, M. Nikparvar, M. Maleki, F. Noohi, S.Z.M. Ojaghighi Haghighi, P. Nakhostin Davari, H. Bakhshandeh Tehran University of Medical Sciences, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran
428
13:00 FREQUENCY OF IMPLANTABLE DEFIBRILLATOR (ICD) USE IN SEVERE SYSTOLIC HEART FAILURE AND EFFECTS ON MORTALITY
R. Al-Najjar, T. Abu Sharifeh, A. Al Emam, A. Khanfar, W.I. Khalife, University of Texas Medical Branch, Galveston, TX, USA
429
13:15 BETA BLOCKER UPTITRATION POST CRT: A SINGLE CENTER EXPERIENCE
F.A. McGrew, E.E. Johnson, M.A. Coppess, J. Foon, S.B. Charlton, T.A. Charlton, J.J. Sims, Stern Cardiovascular Clinic, Germantown, TN, USA
 
430
13:30 PROBNP AND TROPONIN COMBINED IS A STRONGER PREDICTOR OF READMISSIONS COMPARED TO PROBNP ALONE IN CHF PATIENTS
N.C. Bhalodkar, A. Alvi, R. Alvi, U. Khan, J. N. Bella, M. Afshar, Bronx-Lebanon Hospital Center affiliated with Albert Einstein College of Medicine, Bronx, NY, USA
431
13:45 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 30,2012
11:15 - 13:45   HALL C
  S35   Session:  
ACUTE CORONARY SYNDROMES: DETECTION, PREVENTION AND TREATMENT

Chairs:
M.E. Farkouh, Toronto, ON, Canada
Y. Ueda
, Osaka, Japan
 
11:15 DIABETES MELLITUS IS A PREDICTOR OF HYPORESPOSIVENESS TO CLOPIDOGREL BY PLATELET FUNCTION TESTING IN EMERGENCY ROOM
R.K. Sharma, S.W. Erickson, R. Sharma, D.J. Voelker, F. Forsea, H. Dod, V.N. Singh, H.K. Reddy, J.D. Marsh, University of Arkansas for Medical Sciences, Little Rock, AR, USA
432
11:30 MRI EVALUATION OF LEFT VENTRICULAR FUNCTION POST CORONARY OCCLUSION/REPERFUSION AND EMBOLIZATION IN SWINE MODEL
M. Saeed, S.W. Hetts, L. Do, S.M. Sullivan, M.W. Wilson University of California San Francisco, CA, USA
433
11:45 ANTIDEPRESSANT USE, SEROTONIN TRANSPORTER AFFINITY, AND REINFARCTION AMONG PATIENTS RECEIVING CLOPIDOGREL: A POPULATION-BASED STUDY
N. Fnais, M. Alshaikh, Z. Yao, T. Gomes, D. Juurlink, M. Mamdani, King Saud University, Riyadh, Saudi Arabia
434
12:00 SERUM CORIN IS REDUCED AND PREDICTS ADVERSE OUTCOME IN NON S-T ELEVATION ACUTE CORONARY SYNDROME
A. Peleg, Y. Hasin, Poriya Hospital, Tiberias, Israel
435
12:15 TRANSRADIAL PERCUTANEOUS CORONARY ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION
J.M. Telayna
, R.A. Costantini, C. Garcia, Hospital Universitario Austral, Buenos Aires, Argentina
436
12:30 A SINGLE CENTER REAL WORLD COMPARISON OF PROCEDURE TIMES IN THE TRANSRADIAL AND TRANSFEMORAL APPROACHES TO PRIMARY PCI
M.J. Martinelli, K.M. Forbush, M.E. Sturm, C.L. Lasky, M. Fecko, St. Peter's Hospital, Albany, NY, USA
437
12:45 DIFFERENCES IN THE USE OF CARDIAC PROCEDURES BETWEEN WOMEN AND MEN FOLLOWING HOSPITAL ADMISSION WITH ACUTE MYOCARDIAL INFARCTION: IS THE GAP GETTING NARROWER?
N.N. Singh, V.N. Singh, J. Levine, N.N. Singh, M. Nelson, L. Marlow, Suncoast Cardiovascular Research, St Petersburg, FL, USA
438
13:00 CHALLENGES IN THE MANAGEMENT OF POSTPARTUM SPONTANEOUS CORONARY ARTERY DISSECTION
A.G. Truesdell, J. Li, G.A. Delgado, J.D. Abbott, M.K. Atalay, A.K. Singh Warren Alpert Medical School of Brown University, Providence, RI, USA
439
13:15 ETHNIC VARIATIONS IN PRESENTATION AND DOOR TO BALLOON TIME IN PATIENTS WITH STEMI
K. Heretis, E. Shlofmitz, M. Balek, C. Park, A.J. Buda New York Hospital of Queens, Weill-Cornell Medical College, New York, NY, USA
440
13:30 REVASCULARIZATION WITH PERCUTANEOUS TECHNIQUES OR SURGERY IS ASSOCIATED WITH IMPROVED IN-HOSPITAL SURVIVAL IN ELDERLY PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION
V.N. Singh
, N.N. Singh, J. Levine, N.N. Singh, M. Nelson, L. Marlow University of South Florida College of Medicine, Tampa, FL, USA
441
13:45 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  


 


 

 

Affiliated with

 

    international academy of cardiology

Endorsed by